2.7.1.82: ethanolamine kinase
This is an abbreviated version!
For detailed information about ethanolamine kinase, go to the full flat file.
Word Map on EC 2.7.1.82
-
2.7.1.82
-
choline
-
phosphatidylethanolamine
-
phosphoethanolamine
-
cdp-ethanolamine
-
phosphocholine
-
kennedy
-
ptdetn
-
cdp-choline
-
setbp1
-
medicine
- 2.7.1.82
- choline
- phosphatidylethanolamine
- phosphoethanolamine
- cdp-ethanolamine
- phosphocholine
-
kennedy
-
ptdetn
- cdp-choline
-
setbp1
- medicine
Reaction
Synonyms
CEK4, choline/ethanolamine kinase, EKI, EKI1, ethanolamine kinase, ethanolamine kinase 1, ethanolamine kinase 2, ethanolamine phosphokinase, Etn kinase, EtnK, ETNK1, Etnk2, kinase, ethanolamine (phosphorylating), More, PfEK, Treki1
ECTree
Advanced search results
Expression
Expression on EC 2.7.1.82 - ethanolamine kinase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
substantial induction of splicing variant ek2alpha mRNA expression in response to trichostatin A treatment in Hep-G2 cells, the elevated ek2alpha mRNA expression may be due to the accumulation of acetylated histones H3 and H4, located around the promoter regions. Trichostatin A may also induce the recruitment of euchromatic markers and RNA polymerase II to the transcription factor complex that binds to the promoter, thus facilitating gene transcription
treatment of HCT-116 cells with trichostatin A (TSA), a histone deacetylase inhibitor, significantly upregulates the eki1 promoter activity through the Sp(-40/-31) site and increases the endogenous expression of gene eki1. Trichostatin A increases the binding of Sp1, Sp3 and RNA polymerase II to the ek1 promoter in HCT116 cells, molecular mechanism, overview. The effect of TSA on ek1 promoter activity is cell-line specific as TSA treatment does not affect ek1 promoter activity in Hep-G2 cells